Innovative Developments in Acute Lymphocytic Leukemia (ALL) Treatments Global Pipeline Report 2024 [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
Global insights into the advancing pipeline of therapeutics for Acute Lymphocytic Leukemia (ALL) have revealed a diverse range of more than 130 potential new drugs. Investigational treatments are being developed by over 125 companies worldwide, with an aim to offer improved outcomes for individuals affected by this aggressive form of cancer. Understanding Acute Lymphocytic Leukemia Acute Lymphocytic Leukemia is a rapid-developing leukemia that predominantly affects the lymphocytes within the white blood cells. The condition requires immediate treatment and is characterized by symptoms that mimic the flu or other common ailments, thereby emphasizing the need for heightened awareness and accurate diagnostic modalities. Comprehensive Treatment Assessment Current therapeutic approaches for ALL, including chemotherapy, radiation therapy, stem cell transplant, and targeted therapies, are undergoing extensive evaluation. These treatments are crucial for halting the progression of ca
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals' essential tremor drug falls flat in Phase IIb trial [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Needham & Company LLC from $222.00 to $210.00. They now have a "buy" rating on the stock.MarketBeat
- Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor [Yahoo! Finance]Yahoo! Finance
JAZZ
Earnings
- 5/1/24 - Miss
JAZZ
Sec Filings
- 6/14/24 - Form ARS
- 6/14/24 - Form DEFA14A
- 6/14/24 - Form DEF
- JAZZ's page on the SEC website